Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million). Founded in 1978, Bartels is a world leader in the development and manufacture of diagnostic products for the identification of infectious agents which are cell dependent.
Trinity Biotech buys Bartels
Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million)
From maternity leave to remote working: Submit your work-related questions here
Listen to Inside Business podcast for a look at business and economics from an Irish perspective
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
‘Unauthorised’ extension at beachfront property faces likely demolition order, judge rules
Andy Robertson to stay at Liverpool after they pull out of Tottenham talks
Man who falsely claimed injury after traffic collision jailed for over two years
Retired superintendent and four serving gardaí found not guilty of interfering in road traffic prosecutions
Minneapolis shooting: Trump sends ‘border tsar’ to report on killing of Alex Pretti
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning